Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Midazolam in Healthy Male Volunteers
NCT02256748
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
BIRT 2584 XX
DRUG:
Midazolam
Sponsor
Boehringer Ingelheim